ctDNA reveals hidden relapse risk as a clinician-scientist builds Northwell’s GI trials, uses AI for recruitment, and spotlights ASCO 2026 drugs.
Nicholas Hornstein, MD, PhD
Advertisement
Nicholas Hornstein, MD, PhD, is a hematologist-oncologist and assistant professor at Northwell Health's Zucker School of Medicine.
Articles by Nicholas Hornstein, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Approves Palbociclib Plus Anti-HER2 and Endocrine Therapy as Maintenance in Breast Cancer
2
Deep Responses Support Push for CAR T-Cell Therapy in AL Amyloidosis
3
FDA Approves Sacituzumab Govitecan for First-Line TNBC Treatment
4
Ziftomenib Combo Shows Frontline Potential in AML
5